Form 4: DocGo Director Ira Smedra Granted 150,000 RSUs

DocGo Inc. Director Ira Smedra was granted 150,000 restricted stock units, vesting in December 2026, increasing his beneficial ownership to 240,999 shares.

Summary

• Ira Smedra, a Director of DocGo Inc. (DCGO), was granted 150,000 restricted stock units (RSUs).
• The transaction date for this grant was December 12, 2025.
• These RSUs were granted at a price of $0 per unit.
• The RSUs will vest on December 12, 2026, under the terms of the Issuer's 2021 Stock Incentive Plan.
• Each RSU represents the right to receive one share of DocGo Common Stock upon vesting.
• Following this transaction, Ira Smedra beneficially owns a total of 240,999 shares of Common Stock.

Sentiment

Score: 6

Explanation: The grant of restricted stock units to a director is generally viewed as a positive signal, as it aligns the director's financial interests with the long-term performance of the company and shareholder value. It reflects a commitment from the insider.

Positives

• The grant of 150,000 restricted stock units to Director Ira Smedra aligns his long-term interests with those of shareholders.
• The vesting schedule through December 12, 2026, indicates a commitment to the company's future performance.

Future Outlook

The filing indicates a future vesting event for 150,000 restricted stock units on December 12, 2026, which will convert into common stock, subject to the terms of the 2021 Stock Incentive Plan.

Industry Context

The grant of restricted stock units to a director is a common practice in publicly traded companies across various industries, including healthcare technology, to incentivize long-term performance and align management interests with shareholder value.

Comparison to Industry Standards

• The use of restricted stock units (RSUs) as a form of equity compensation for directors is a standard practice across many industries, including healthcare and technology, aligning with compensation strategies seen at companies like Teladoc Health (TDOC) or Amwell (AMWL).
• The grant of 150,000 RSUs to a director, while substantial, is within the typical range for non-executive directors at companies of similar market capitalization to DocGo, reflecting a common approach to long-term incentive plans.

Corporate Governance

Related Party Transactions

• The grant of 150,000 restricted stock units to Ira Smedra, a Director, constitutes a related party transaction as it involves compensation from the company to an insider. This is a standard form of equity compensation.

Stakeholder Impact

• Shareholders: The grant of RSUs to a director can align management's interests with shareholder value, potentially leading to better long-term performance.
• Director (Ira Smedra): Receives equity compensation, increasing his stake and incentivizing his commitment to the company's success.

Next Steps

• Vesting of 150,000 restricted stock units on December 12, 2026, converting into common stock.

Key Dates

Keywords

DocGo, DCGO, Ira Smedra, Form 4, Restricted Stock Units, RSU, Director, Insider Transaction, Stock Incentive Plan, Equity Compensation